Your shopping cart is currently empty

URAT1 inhibitor11 (Compound 7) is a potent URAT1 inhibitor, exhibiting an IC50 of 0.18 μM. It effectively reduces uric acid levels in zebrafish with hyperuricemia induced by Potassium oxonate and Xanthinesodium salt.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | 10-14 weeks | 10-14 weeks | |
| 50 mg | Inquiry | 10-14 weeks | 10-14 weeks |
| Description | URAT1 inhibitor11 (Compound 7) is a potent URAT1 inhibitor, exhibiting an IC50 of 0.18 μM. It effectively reduces uric acid levels in zebrafish with hyperuricemia induced by Potassium oxonate and Xanthinesodium salt. |
| In vitro | URAT1 inhibitor 11, after 60 minutes, demonstrates greater stability in mouse liver microsomes compared to Benzbromarone, with respective residual rates of 83.2% and 4.5%. |
| In vivo | URAT1 inhibitor 11 (0.5 μM) effectively reduces uric acid levels in zebrafish with hyperuricemia induced by Potassium oxonate and Xanthine sodium salt, thereby exhibiting a urate-lowering effect. |
| Molecular Weight | 392.35 |
| Formula | C20H16F4N2O2 |
| Cas No. | 2416416-13-0 |
| Smiles | O=C(O)CCCN(C=1C=CC=C(F)C1)C=2C=CN=C3C=CC(=CC32)C(F)(F)F |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.